| Literature DB >> 10930313 |
M Bodo1, T Baroni, F Carinci, E Becchetti, C Conte, C Bellucci, F Pezzetti, M Calvitti, S Bellocchio, G Stabellini, P Carinci.
Abstract
The present study provides the first evidence that fibroblasts obtained from patients affected by Crouzon syndrome, a rare craniosynostosis, despite mutations in the high-affinity bFGF receptor retain their capacity to respond to bFGF. The growth factor reduces IL-1 secretion, downregulates biglycan and procollagen alpha(1)(I), and increases betaglycan expression. Since betaglycan is a co-receptor for bFGF signalling, an alternative signal transduction pathway is suggested in Crouzon fibroblasts, to explain the documented changes in ECM macromolecule production. Copyright 2000 Academic Press.Entities:
Mesh:
Substances:
Year: 2000 PMID: 10930313 DOI: 10.1006/cyto.1999.0730
Source DB: PubMed Journal: Cytokine ISSN: 1043-4666 Impact factor: 3.861